Literature DB >> 30444976

Recurrent short-term hypoglycemia and hyperglycemia induce apoptosis and oxidative stress via the ER stress response in immortalized adult mouse Schwann (IMS32) cells.

Ayako Kato1, Yasuaki Tatsumi1, Hideji Yako2, Kazunori Sango2, Tatsuhito Himeno3, Masaki Kondo3, Yoshiro Kato3, Hideki Kamiya3, Jiro Nakamura3, Koichi Kato4.   

Abstract

Hypoglycemia and fluctuating high or low glucose conditions are under-appreciated sources of oxidative stress contributing to diabetic neuropathy. We investigated the effects of recurrent short-term hypoglycemia and hyperglycemia, on apoptosis and oxidative stress in Schwann cells. Immortalized adult mouse Schwann (IMS32) cells were exposed to five different glucose treatments over 3 days: 1) normal glucose (NG), 2) constant low glucose (LG), 3) constant high glucose (HG), 4) intermittent low glucose (ILG; 1 h three times per day), 5) intermittent high glucose (IHG; 1 h three times per day). Cell viability was decreased by all treatment variants, in comparison to NG. Thiobarbituric acid reactive substance (TBARS) levels were increased by HG, LG, IHG, and ILG. High glucose (HG and IHG) and low glucose (LG and ILG) increased the expression of cleaved caspase-3 and reduced that of Bcl-2. In addition, endoplasmic reticulum (ER) stress-responsive transcription factor C/EBP homologous protein (CHOP) expression was increased under low and high glucose conditions. Cell death and oxidative stress induced by HG, LG, IHG, and ILG were significantly reduced by 4-phenyl butyric acid (4-PBA), an ER stress inhibitor. These findings indicate that recurrent short-term hypoglycemia and hyperglycemia induce apoptosis and oxidative stress via the ER stress response in Schwann cells.
Copyright © 2018 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  Diabetic neuropathy; Endoplasmic reticulum (ER) stress; Glucose fluctuation; Hyperglycemia; Hypoglycemia; Oxidative stress; Schwann cells

Mesh:

Substances:

Year:  2018        PMID: 30444976     DOI: 10.1016/j.neures.2018.11.004

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  6 in total

Review 1.  Ischemic brain injury in diabetes and endoplasmic reticulum stress.

Authors:  Ashish K Rehni; Sunjoo Cho; Kunjan R Dave
Journal:  Neurochem Int       Date:  2021-11-01       Impact factor: 3.921

2.  4-Phenylbutyrate Mitigates the Motor Impairment and Dopaminergic Neuronal Death During Parkinson's Disease Pathology via Targeting VDAC1 Mediated Mitochondrial Function and Astrocytes Activation.

Authors:  Shubhangini Tiwari; Parul Gupta; Abhishek Singh; Swati Chaturvedi; M Wahajuddin; Amit Mishra; Sarika Singh
Journal:  Neurochem Res       Date:  2022-08-03       Impact factor: 4.414

Review 3.  Endoplasmic reticulum stress in the acute intestinal epithelial injury of necrotizing enterocolitis.

Authors:  Ethan Lau; Carol Lee; Bo Li; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2021-06-12       Impact factor: 1.827

4.  Docosahexaenoic Acid Suppresses Oxidative Stress-Induced Autophagy and Cell Death via the AMPK-Dependent Signaling Pathway in Immortalized Fischer Rat Schwann Cells 1.

Authors:  Yasuaki Tatsumi; Ayako Kato; Naoko Niimi; Hideji Yako; Tatsuhito Himeno; Masaki Kondo; Shin Tsunekawa; Yoshiro Kato; Hideki Kamiya; Jiro Nakamura; Koji Higai; Kazunori Sango; Koichi Kato
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

5.  Specific gene expression in type 1 diabetic patients with and without cardiac autonomic neuropathy.

Authors:  Joanna Gastol; Anna Polus; Maria Biela; Urszula Razny; Lukasz Pawlinski; Bogdan Solnica; Beata Kiec-Wilk
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

6.  Lipopolysaccharide-binding protein is a distinctive biomarker of abnormal pain threshold in the general Japanese population.

Authors:  Kazuhiro Kudoh; Hiroki Mizukami; Chieko Itabashi; Nobuo Fuke; Sho Osonoi; Yuki Takeuchi; Kanichiro Wada; Akiko Igawa; Saori Ogasawara; Yasuyuki Ishibashi; Kenichi Hakamada; Soroku Yagihashi; Shigeyuki Nakaji
Journal:  BMJ Open Diabetes Res Care       Date:  2020-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.